APA

Jaziri R., Lobbens S., Aubert R., Péan F., Lahmidi S., Vaxillaire M., Porchay I., Bellili N., Tichet J., Balkau B., Froguel P., Marre M. & Fumeron F. (20060626). The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. : Diabetes.

Chicago

Jaziri Riphed, Lobbens Stephane, Aubert Roberte, Péan Franck, Lahmidi Saida, Vaxillaire Martine, Porchay Isabelle, Bellili Naïma, Tichet Jean, Balkau Beverley, Froguel Philippe, Marre Michel and Fumeron Frédéric. 20060626. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. : Diabetes.

Harvard

Jaziri R., Lobbens S., Aubert R., Péan F., Lahmidi S., Vaxillaire M., Porchay I., Bellili N., Tichet J., Balkau B., Froguel P., Marre M. and Fumeron F. (20060626). The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. : Diabetes.

MLA

Jaziri Riphed, Lobbens Stephane, Aubert Roberte, Péan Franck, Lahmidi Saida, Vaxillaire Martine, Porchay Isabelle, Bellili Naïma, Tichet Jean, Balkau Beverley, Froguel Philippe, Marre Michel and Fumeron Frédéric. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. : Diabetes. 20060626.